Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : Controlled Drugs

Sort by: Newest first Oldest first A-Z Z-A

  • Crowdfunding is being sought by scientists to support an imaging study showing the effects of LSD on the brain.

    Scientists use crowdfunding to boost research into LSD effects on the brain Subscription

    6 MAR 2015 12:53 By Ingrid Torjesen

    Scientists have turned to crowdfunding to support an imaging study showing the effects of LSD on the brain, the first to be conducted in the UK.

  • PSNC briefing on drug driving laws Subscription

    20 FEB 2015 14:38

    The Pharmaceutical Services Negotiating Committee (PSNC) has produced a briefing on the drug driving legislation coming into force 2 March 2015. It is designed to help pharmacy teams understand the implications for patients. The briefing can be accessed on the PSNC’s website. 

  • Drug driving reference guide Subscription

    16 FEB 2015 12:06

    The Royal Pharmaceutical Society (RPS) has created a new quick reference guide to support pharmacists and their patients with changes to drug driving laws, which come into effect on 2 March 2015, in England and Wales. The resource is available on the RPS’s website to members of the Society. 

  • Suvorexant (Belsomra), a first-in-class orexin receptor antagonist drug, is now available on prescription in the United States for adults with insomnia

    Insomnia drug suvorexant launched in the United States Subscription

    5 FEB 2015 15:51
    Comments (1)

    Suvorexant (Belsomra), a first-in-class orexin receptor antagonist drug, is now available on prescription in the United States for adults with insomnia.

  • Rescheduling of 4-hydroxy-n-butyric acid Subscription

    8 JAN 2015 15:48

    On 7 January 2015, 4-hydroxy-n-butyric acid (GHB) was rescheduled as a Schedule 2 Controlled Drug (CD POM). It was previously a Schedule 4 Part 1 Controlled Drug. More information is available on the Royal Pharmaceutical Society website.

  • Drug driving laws Subscription

    18 DEC 2014 10:42

    The Department for Transport has asked pharmacies to help drivers understand the drug driving laws that come into effect in 2015. As part of a campaign to raise awareness of the new laws, from February 2015 pharmacy teams can display posters and provide leaflets to customers in the pharmacy. A ‘partner pack’ has been developed that helps explain the new rules. Pharmacy owners can

  • Uruguay delays plans to allow the sale of cannabis for recreational purposes in pharmacies

    Uruguay delays plans to sell cannabis in pharmacies Subscription

    4 DEC 2014 11:13 By Bernard Murphy

    Marijuana will not be sold in pharmacies in Uruguay until March 2015, the National Drugs Board (JND) has announced.

  • Medicinal cannabis widely used in Israel Subscription

    2 DEC 2014 12:06 By Monty Goldin

    I would like to add to David Nutt’s piece about medicinal cannabis (The Pharmaceutical Journal 2014;293:560). Cannabidiol and d9-tetrahydrocannabinol were discovered by scientists in Israel and medicinal cannabis is now widely used there for a number of conditions. It is grown in secret locations under strict security and is prescribed by doctors registered to do so. There is now a facility ...

  • The stringent laws on the use of cannabis for medicinal reasons does not help patients, clinicians and researchers

    Medicinal cannabis: time for a comeback? Subscription

    19 NOV 2014 14:36 By David Nutt
    Comments (2)

    The stringent laws on cannabis do no favours for patients, clinicians and researchers.

  • Controlled drugs guideline Subscription

    7 NOV 2014 10:00

    The National Instititute for Health and Care Excellence (NICE) is developing a guideline on the safe use and management of controlled drugs and is currently consulting on the draft scope. The guideline will provide recommendations for the systems and processes relating to the safe use and management of controlled drugs. The consultation will be available from the NICE website until 1 ...

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.